Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

被引:0
|
作者
Jonas Wallström
Kjell Geterud
Kimia Kohestani
Stephan E. Maier
Marianne Månsson
Carl-Gustaf Pihl
Andreas Socratous
Rebecka Arnsrud Godtman
Mikael Hellström
Jonas Hugosson
机构
[1] University of Gothenburg,Department of Radiology, Institute of Clinical Sciences, Sahlgrenska Academy
[2] Region Västra Götaland,Department of Radiology
[3] Sahlgrenska University Hospital,Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy
[4] University of Gothenburg,Department of Urology
[5] Region Västra Götaland,Department of Pathology, Institute of Biomedicine, Sahlgrenska Academy
[6] Sahlgrenska University Hospital,undefined
[7] University of Gothenburg,undefined
来源
European Radiology | 2021年 / 31卷
关键词
Multiparametric magnetic resonance imaging; Prostatic neoplasms; Early detection of cancer; Contrast media;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:8692 / 8702
页数:10
相关论文
共 50 条
  • [21] Cancer Lesion Screening in MRI for Prostate Biopsy
    Chen, Yunjie
    Zhang, Liangbin
    Ma, Wenjun
    Zhang, Su
    Gao, Fen
    Zhu, Yunkai
    Chen, Yaqing
    PROCEEDINGS OF 2016 IEEE 13TH INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING (ICSP 2016), 2016, : 23 - 28
  • [22] Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial
    Murtola, Teemu J.
    Tammela, Teuvo L. J.
    Maattanen, Liisa
    Huhtala, Heini
    Platz, Elizabeth A.
    Ala-Opas, Martti
    Stenman, Ulf-Hakan
    Auvinen, Anssi
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) : 1650 - 1659
  • [23] Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Goteborg Prostate Cancer Screening 2 Trial
    Wallstrom, Jonas
    Geterud, Kjell
    Kohestani, Kimia
    Maier, Stephan E.
    Pihl, Carl-Gustaf
    Socratous, Andreas
    Stranne, Johan
    Arnsrud-Godtman, Rebecka
    Mansson, Marianne
    Hellstrom, Mikael
    Hugosson, Jonas
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (01): : 54 - 60
  • [24] The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The prostate cancer screening results in context
    Berg, Christine D.
    ACTA ONCOLOGICA, 2011, 50 : 12 - 17
  • [25] Combining Multiparametric MRI and PSA Density for Improved Diagnostic Accuracy in Prostate Cancer
    Celikkaleli, Ferhat
    Ozden, Cuneyt
    Bulut, Suleyman
    Gokkaya, Cevdet Serkan
    Aktas, Binhan Kagan
    Kizilkan, Yalcin
    Senel, Samet
    Sagir, Sueleyman
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2024, 23 (04): : 111 - 115
  • [26] Prostate Cancer Screening and Prostate MRI: Hypotheses Founded on Uncertain Evidence
    Takahashi, Takeshi
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2024, 222 (05)
  • [27] Rethinking prostate cancer screening: could MRI be an alternative screening test?
    Eldred-Evans, David
    Tam, Henry
    Sokhi, Heminder
    Padhani, Anwar R.
    Winkler, Mathias
    Ahmed, Hashim U.
    NATURE REVIEWS UROLOGY, 2020, 17 (09) : 526 - 539
  • [28] Rethinking prostate cancer screening: could MRI be an alternative screening test?
    David Eldred-Evans
    Henry Tam
    Heminder Sokhi
    Anwar R. Padhani
    Mathias Winkler
    Hashim U. Ahmed
    Nature Reviews Urology, 2020, 17 : 526 - 539
  • [29] Prostate cancer screening with MRI does not differ from PSA only for detection but reduces biopsies and overdiagnosis
    Wilt, Timothy J.
    Dahm, Philipp
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (08) : JC94 - JC94
  • [30] Prostate cancer screening-stepping forward with MRI
    Padhani, Anwar R. R.
    Schoots, Ivo G. G.
    EUROPEAN RADIOLOGY, 2023, 33 (10) : 6670 - 6676